GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Larson Financial Group LLC

Larson Financial Group LLC lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 21.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,807 shares of the company’s stock after acquiring an additional 665 shares during the period. Larson Financial Group LLC’s holdings in GE HealthCare Technologies were worth $298,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in GEHC. D1 Capital Partners L.P. acquired a new stake in shares of GE HealthCare Technologies in the third quarter worth approximately $268,159,000. Van ECK Associates Corp boosted its stake in shares of GE HealthCare Technologies by 107.3% in the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company’s stock worth $378,520,000 after acquiring an additional 2,506,417 shares during the last quarter. State Street Corp boosted its stake in shares of GE HealthCare Technologies by 7.8% in the third quarter. State Street Corp now owns 18,615,890 shares of the company’s stock worth $1,747,101,000 after acquiring an additional 1,347,114 shares during the last quarter. Massachusetts Financial Services Co. MA acquired a new stake in shares of GE HealthCare Technologies in the third quarter worth approximately $93,713,000. Finally, Jennison Associates LLC boosted its stake in shares of GE HealthCare Technologies by 124.5% in the fourth quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock worth $133,659,000 after acquiring an additional 948,017 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $85.36 on Tuesday. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $39.03 billion, a P/E ratio of 19.71, a P/E/G ratio of 3.19 and a beta of 1.13. The stock’s fifty day moving average is $86.91 and its two-hundred day moving average is $86.17.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Citigroup lifted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company boosted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.